Navigation Links
Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
Date:4/10/2008

SAN DIEGO, April 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will release its first quarter 2008 financial results on Monday, April 28, 2008 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET. Henry L. Nordhoff, chairman and chief executive officer, and Herm Rosenman, senior vice president, finance, and chief financial officer, will host the call.

The conference call will be webcast live and may be accessed on the investors section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 866-421-6934 (U.S.) or 203-369-0825 (international).

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
2. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
3. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
4. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
5. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
6. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
7. LeMaitre Vascular Announces Changes to Its Executive Management Team
8. Methodist Healthcare - Memphis Hospitals Announces Termination of Tender Offers
9. Crdentia Announces Appointments of David Jenkins and Raymond Dunn to Board of Directors
10. IHHI Announces Chief Compliance Officer Appointment
11. The Leukemia & Lymphoma Society Announces Appointment of New President and CEO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... No more letters from the North Pole, Tex...ext messages from Santa , ...e operational efficiencies at the North Pole Santa...hildren all over the globe informed of his Christm...rsquo;s research department have identified a larg...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a l...lina, today announced the expansion of its service...tist, Dr. Doug Macmillan. , ...al is pleased to announce that Dr. Doug Macmillan,...leted an additional advanced training seminar. RT...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free...f Yaz and Yasmin birth control pills who have suff...ism, Stroke, Heart Attack or other related cardiac...n call toll free at 1-800-856-6405 or go to the fi...d fill out an online case evaluation form. , ...
(Date:11/25/2009)...TY,Mo.,Nov.25/PRNewswire/--TheBartleHallConvention...alcliniconDec.9-10,whenKansasCityhoststhelatestina..., "Thisfreecliniceventhasthepotentialtobethebigges...toneandbeheldonweekdaysinsteadofoveraweekend,"Sher...inicandpresidentoftheNationalAssociationofFreeClin...
(Date:11/25/2009)...ndCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc....I)coilsandsoftwareandCalgaryScientificInc.,aleadin...ucedawebversionofAegis(TM)Breast4DAdvancedVisualiz...irsttrulyzero-footprintWebclientbasedmedicalimagin...)platformallowsforzero-footprintaccess-requiringno...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...ragon Medsystems unveiled their new corporate iden...ffective immediately, the company name will be Cal...more than ten years of providing turnkey developme... expansion throughout California," comments Califo...
...ting the protein AEG1 impairs human liver cancer g...s a highly aggressive form of liver cancer and one...Sarkar and colleagues, at Virginia Commonwealth Un...important for HCC progression. They therefore sugg...
...a family history of melanoma may have a greater ri... a study released today that will be presented at ...eting in Seattle, April 25 to May 2, 2009. , The...oma, the deadliest form of skin cancer. Researcher...
...of being killed by lightning, study finds , ...f young athletes in the United States dying of sud...h the same age group being involved in a lightning...rvived cardiac arrest from 1980 to 2006. , Cardio...
...ors recognized for technological breakthroughs , ... Crain,s Cleveland Business , is pleased to annou...gram, which honors outstanding technological achie...l of judges from Northeast Ohio, representing a br...
... times more likely to develop malignancies after r...ealthDay News) -- In an ironic testament to the su...report that women who were treated as children wit...odgkin,s disease. Back in 1950, it was regarded as...
Other Medicine News:Health News:Paragon Medsystems Becomes California MedTech 2Health News:JCI online early table of contents: Feb. 16, 2009 2Health News:JCI online early table of contents: Feb. 16, 2009 3Health News:JCI online early table of contents: Feb. 16, 2009 4Health News:Sudden Cardiac Death Rare in Young Athletes 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 3Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 5Health News:Hodgkin's Survivors Prone to Breast Cancer Later 2Health News:Hodgkin's Survivors Prone to Breast Cancer Later 3
(Date:11/25/2009)...v.25/PRNewswire/--BioTrendsResearchGroup,Inc.relea...t,thefirstinamulti-phasesyndicatedmarketresearchpr...lara,fromproductlaunchthroughthefirstsixmonthsofav...informationfrom75uniqueDermatologistsandqualitativ...nduseofStelara,obstaclestouse,typicalpatienttypes,...
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechnol...thatstopsseverebleeding,wonfirstprizeand$10,000int...rityChallenge2009,companyofficialsannouncetoday. ,...rld,Remedium,steampitchedtheirinventionattheGSCSec...ss. ,, Remedium( www.remediumtechnologies.com )...
(Date:11/25/2009)...,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSkyOne,Me...daq: CSKI ),a,leadingfullyintegratedpharmaceutical...sinthePeople,sRepublicofChina("PRC"),today,announc...stitutefor,theControlofPharmaceuticalandBiological...s:itsDiagnosticKitforHumanProstateSpecific,Antigen...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 1REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 2REPEAT 3A Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positiv 57712 3U S Census Bureau Daily Feature for Sept 20 57708 1Strain on nanocrystals could yield colossal results 14156 1Strain on nanocrystals could yield colossal results 14156 2Strain on nanocrystals could yield colossal results 14156 3
...lls Inc. (BCI), a,biopharmaceutical company utiliz...p compounds that promote the growth of new neurons... diseases, announced today that it has,initiated a...didate,BCI-540, for the treatment of depression wi... expressed by our clinical,investigators who view ...
...Predictable, Extended Exposure with Sustained- ...O, April 17 Data from the first pivotal study of,...ional compound to treat,Restless Legs Syndrome (RL...toms of moderate-to-severe primary RLS compared to...ministered once-daily for 12 weeks., Data from th...
Other Medicine Technology:BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 2Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 3Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 4Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 5Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome 6
ABX Micros IM Hematology Analyzers
Sequitor™ Steerable Guidewire
Rio™ Aspiration Catheter
Reference Lab Interface (RLI)©
Medicine Products: